List of works - Firdos Ahmad

Acquired Glanzmann’s thrombasthenia associated with Hairy cell leukaemia

scientific article published on 07 July 2009

Cardiac fibroblast glycogen synthase kinase-3β regulates ventricular remodeling and dysfunction in ischemic heart

scientific article published on 4 June 2014

Cardiomyocyte-GSK-3α promotes mPTP opening and heart failure in mice with chronic pressure overload

scientific article published on 27 March 2019

Cardiomyocyte-specific deletion of GSK-3β leads to cardiac dysfunction in a diet induced obesity model.

scientific article published on 2 February 2018

Cardiomyocyte-specific deletion of Gsk3α mitigates post-myocardial infarction remodeling, contractile dysfunction, and heart failure

scientific article

Carrier Detection in Glanzmann Thrombasthenia

scientific article published on 01 July 2008

Characterisation of mutations and molecular studies of type 2 von Willebrand disease

scientific article published on 22 November 2012

Characterization of VWF gene conversions causing von Willebrand disease

article

Chronic Neuregulin-1β Treatment Mitigates the Progression of Postmyocardial Infarction Heart Failure in the Setting of Type 1 Diabetes Mellitus by Suppressing Myocardial Apoptosis, Fibrosis, and Key Oxidant-Producing Enzymes

scientific article published in September 2017

Coinheritance of Severe von Willebrand Disease With Glanzmann Thrombasthenia

scientific article published on 10 February 2010

Evidence for non-HFE linked hemochromatosis in Asian Indians

article

Functional characterization of antibodies against heparin-platelet factor 4 complex in heparin-induced thrombocytopenia patients in Asian-Indians: relevance to inflammatory markers

scientific article

GSK-3α is a central regulator of age-related pathologies in mice

scientific article

Gene tracking in a family of novel identical twins affected by severe type-III von Willebrand Disease (vWD).

scientific article published on 14 December 2006

Germline de novo mutations and linkage markers vs. DNA sequencing for carrier detection in von Willebrand disease

scientific article published on 8 April 2014

Glanzmann's thrombasthenia in North Indians: sub classification and carrier detection by flow cytometry

scientific article published in February 2009

Glycogen synthase kinase-3α limits ischemic injury, cardiac rupture, post-myocardial infarction remodeling and death

scientific article

Human genome-wide association and mouse knockout approaches identify platelet supervillin as an inhibitor of thrombus formation under shear stress

scientific article

Impact of 789Ala/Ala genotype on quantitative type of von Willebrand disease.

scientific article

Impact of thrombogenic mutations on clinical phenotypes of von Willebrand disease.

scientific article published on 2 December 2009

Inherited platelet function disorders versus other inherited bleeding disorders: an Indian overview

scientific article

Loss of Adult Cardiac Myocyte GSK-3 Leads to Mitotic Catastrophe Resulting in Fatal Dilated Cardiomyopathy.

scientific article published on 14 March 2016

Modulation of clinical phenotype of Glanzmann's thrombasthenia by thrombogenic mutations

scientific article published on 24 February 2009

Molecular defects in ITGA2B and ITGB3 genes in patients with Glanzmann thrombasthenia

article

Phenotypic and molecular characterisation of type 3 von Willebrand disease in a cohort of Indian patients.

scientific article

Platelet activation markers in evaluation of thrombotic risk factors in various clinical settings

scientific article published on 22 May 2019

Relative contributions of stromal interaction molecule 1 and CalDAG-GEFI to calcium-dependent platelet activation and thrombosis.

scientific article

Response by Zhou et al to Letter Regarding Article, "Loss of Adult Cardiac Myocyte GSK-3 Leads to Mitotic Catastrophe Resulting in Fatal Dilated Cardiomyopathy".

scientific article published on July 2016

Role of RFLP using TspRI for carrier detection in Glanzmann's thrombasthenia: a report on two families

scientific article published on 18 January 2009

The GSK-3 family as therapeutic target for myocardial diseases ⬇️

scientific article

Troponin I-Interacting Protein Kinase

TxA Receptor-Based Vaccination: A Novel Potential Therapeutic Approach to Limit Thrombosis

scholarly article by Firdos Ahmad published 23 June 2018 in Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease

List of works by Firdos Ahmad

Acquired Glanzmann’s thrombasthenia associated with Hairy cell leukaemia

Cardiac fibroblast glycogen synthase kinase-3β regulates ventricular remodeling and dysfunction in ischemic heart

Cardiomyocyte-GSK-3α promotes mPTP opening and heart failure in mice with chronic pressure overload

Cardiomyocyte-specific deletion of GSK-3β leads to cardiac dysfunction in a diet induced obesity model.

Cardiomyocyte-specific deletion of Gsk3α mitigates post-myocardial infarction remodeling, contractile dysfunction, and heart failure

Carrier Detection in Glanzmann Thrombasthenia

Characterisation of mutations and molecular studies of type 2 von Willebrand disease

Characterization of VWF gene conversions causing von Willebrand disease

Chronic Neuregulin-1β Treatment Mitigates the Progression of Postmyocardial Infarction Heart Failure in the Setting of Type 1 Diabetes Mellitus by Suppressing Myocardial Apoptosis, Fibrosis, and Key Oxidant-Producing Enzymes

Coinheritance of Severe von Willebrand Disease With Glanzmann Thrombasthenia

Evidence for non-HFE linked hemochromatosis in Asian Indians

Functional characterization of antibodies against heparin-platelet factor 4 complex in heparin-induced thrombocytopenia patients in Asian-Indians: relevance to inflammatory markers

GSK-3α is a central regulator of age-related pathologies in mice

Gene tracking in a family of novel identical twins affected by severe type-III von Willebrand Disease (vWD).

Germline de novo mutations and linkage markers vs. DNA sequencing for carrier detection in von Willebrand disease

Glanzmann's thrombasthenia in North Indians: sub classification and carrier detection by flow cytometry

Glycogen synthase kinase-3α limits ischemic injury, cardiac rupture, post-myocardial infarction remodeling and death

Human genome-wide association and mouse knockout approaches identify platelet supervillin as an inhibitor of thrombus formation under shear stress

Impact of 789Ala/Ala genotype on quantitative type of von Willebrand disease.

Impact of thrombogenic mutations on clinical phenotypes of von Willebrand disease.

Inherited platelet function disorders versus other inherited bleeding disorders: an Indian overview

Loss of Adult Cardiac Myocyte GSK-3 Leads to Mitotic Catastrophe Resulting in Fatal Dilated Cardiomyopathy.

Modulation of clinical phenotype of Glanzmann's thrombasthenia by thrombogenic mutations

Molecular defects in ITGA2B and ITGB3 genes in patients with Glanzmann thrombasthenia

Phenotypic and molecular characterisation of type 3 von Willebrand disease in a cohort of Indian patients.

Platelet activation markers in evaluation of thrombotic risk factors in various clinical settings

Relative contributions of stromal interaction molecule 1 and CalDAG-GEFI to calcium-dependent platelet activation and thrombosis.

Response by Zhou et al to Letter Regarding Article, "Loss of Adult Cardiac Myocyte GSK-3 Leads to Mitotic Catastrophe Resulting in Fatal Dilated Cardiomyopathy".

Role of RFLP using TspRI for carrier detection in Glanzmann's thrombasthenia: a report on two families

The GSK-3 family as therapeutic target for myocardial diseases ⬇️

Troponin I-Interacting Protein Kinase

TxA Receptor-Based Vaccination: A Novel Potential Therapeutic Approach to Limit Thrombosis